Last week we brought you a full report on a company and healthcare trend that has captivated investors this year. The market for telehealth technology has taken the world by storm. In fact, Deloitte reports(1) that “telehealth can enable healthcare systems to extend high-quality care to patients throughout their journey across the care spectrum.”
Healthcare is one of the highest growth industries in the world, so it’s no wonder why companies are aiming at exploiting the pent-up demand for easier access to allow patients the ability to receive care via the use of new technologies such as telehealthcare.
Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) Takes Aim At New Highs
On October 31 we published the article, “Ever Hear Of Connecting The Dots? Consider This Your Heads Up.” Though it was Halloween, there were no tricks to this treat. We wanted to make sure everyone understood the opportunities that this market is presenting right now and emphasize the fact that you don’t need to be Appl Inc. or Amazon to deliver real gains to investors.
Enter Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI). This company is brand new to the North American public markets. It just became eligible for the US Depository Trust late last month. Throughout the last few months, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has been building the framework for what could be a great push for market share in the ever-growing telehealth technology space. Also, the company is focusing on the Canadian markets to take full advantage of the general lack of access that the “free” healthcare system offers (or doesn’t offer) to the country.
Now, why do we say this? Statistics from Premier Health’s subsidiary, HealthVue, show that roughly 15% of Canadians aged 12 and older don’t have a primary care physician. On top of this, nearly two-thirds of seniors are also unable to get a same-or next-day appointment. This contributes to about 7 in 10 Canadians avoiding seeing a doctor when they are sick.
Here’s where Premier Health & HealthVue can make substantial headway within the marketplace. HealthVue has an ecosystem of over 100,000 active patients, and according to the company, they also have plans to “rapidly increase that number both domestically and internationally.” Unlike other telehealth companies, HealthVue also has four clinics in British Columbia with plans to expand to the rest of Canada via its telemedicine model.
The benefit for Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) is that it can tap into the existing payment structure that Canada offers. Unlike the US, the telemedicine visits are already covered by the provincial health insurance plans in several provinces, so there is no cost to the patient to access this service. HealthVue expects to make the first version of the app available to their patients in Q4-18.
Recent Market Reaction: Strong Uptrend
After sending out our report, we’ve been flooded with attention on both the site and our email subscribers. The interest that has built this week alone indicates to us that the sector and company are gaining attention in the market. Just look at the last few days and we think that you’ll see things have started to “wake up” for this company in the market:
Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) is brand new but the fact that volume and price have climbed the way they have over the last few days suggests to us that this momentum could be just the beginning. Remember, our goal is to bring new ideas to you, and if you made a point to read over this article, then you already know that some of the biggest breakout companies of the year started in a similar way: early momentum building and price beginning to steadily climb.
In our opinion, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) is far from “just another healthcare company.” What they’ve begun to achieve could set the stage for something even more significant for the company, its technology, and the industry as we know it.
The Trail Ahead Could Breed More Joint Venture Opportunities
On October 11, 2018, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) announced their selection of Reliq Health Technologies Inc. as its exclusive technology partner. Reliq is “a healthcare technology company that specializes in developing innovative software as a service solution for the $30 billion community carer market.”
Reliq’s mission, like their new partner Premier Health (OTC: PHGRF) (CSE: PHGI), is to create technological solutions to “allow patients to receive high-quality care in the home or other community-based settings, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.”
According to this selection, Premier Health (OTC: PHGRF) (CSE: PHGI), will look to Reliq to further HealthVue’s telemedicine system by incorporating their technology platform to power the HealthVue patient app. The HealthVue app, powered by Reliq, “will allow patients to book appointments, see their GP or specials, review their chart, chat with clinic staff and pharmacists, refill prescriptions and share health data collected in the home with their HealthVue care team,” said Dr. Essam Hamza, MD, CEO of HealthVue.
But this could be just the start, and the main reason is that big pharmacies and healthcare systems are beginning to see the light. The resulting success could open big doors for the global market and for companies like Premier Health (OTC: PHGRF) (CSE: PHGI) to get a piece of the pie. Just look at some of the leading pharmacies aiming telemedicine:
- Rite Aid (RAD), the third largest pharmacy in America, has begun searching for a useful telehealth technology for its customers both in store and virtually.
- Walgreens (WBA) is connecting with more than a dozen healthcare providers, working to launch a new virtual marketplace used to join its online customers with store- and community-based services.
- CVS has even begun to explore opportunities in telehealth with early ventures. The CVS Pharmacy app leverages back-end technology of telemedicine to offer the service to its subscribers.
The “Big Three” in the pharmacy industry are looking for the advantage and telemedicine could give them just that. The move follows the trends of a new consumer and the tendency to shift care outside of hospitals and clinics to where patients already are.
Market Opportunity Indicates Rapid Growth
Telemedicine is also becoming a more significant part of health care treatment in rural areas, and more hospitals are embracing video consultations. A May 2017 study(2) found that from 2004 to 2014, use of telemedicine for mental health visits among rural Americans on Medicare increased an average of 45% per year.
Other reports(3) from firms like Polaris Market Research & Consulting found that the global telehealth market was valued at $3.1 Billion in 2017 and is anticipated to reach $16.7 Billion by 2025 growing at a CAGR of 23.5%. After observing this kind of rapid expansion within a short period, it stands to reason that not only is healthcare in for a change but also calls for more attention to be placed on companies getting involved early on.
The opportunity to expand beyond the US and into Canada could offer companies within this industry an even greater opportunity, as healthcare systems are unique in each country. With telemedicine making patient care that much more accessible and the evolution to a mobile society, this technology could become a significant catalyst for the healthcare industry. This is where Premier Health (OTC: PHGRF) (CSE: PHGI) could have the upper hand and a big reason why the markets have just begun to pay closer attention to companies within the telemedicine space.
- Deloitte Telehealth Report: https://www2.deloitte.com/us/en/pages/public-sector/articles/empowering-patients-with-telehealth.html
- May 2017 Study: http://content.healthaffairs.org/content/36/5/909.abstract
- Polaris Market Research: https://www.polarismarketresearch.com/press-releases/telehealth-market/
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full disclaimer.
ROKU Stock On A Surge After Its Head-Turning Q2 Results
Roku Inc (NASDAQ:ROKU) stock, the video-streaming pioneer is performing quite well in the Wall Street. The company is expected to go even as high as $150 as projected by analyst Laura Martin. More and more advertisers are using the platform instead of the traditional television for advertising their products and services.
An increased number of people are skipping video ads on television. Martin continues to keep ROKU stock as one of the top picks for mid-cap companies this year seeing the potential of a further stock price increase.
The platform’s popularity which is measured by variables like audience count, usage and average revenue per user increased greatly resulting in a humungous growth. Last week, the stocks of the company rose by 25% post the impressive performance in yet another quarter.
The revenue reported a rise by 59% in Q2, 86% of which was due to a surge in the revenue generated through the platform. While a few years earlier, the revenue was dominated by the sales of the low-margin device, now over two-thirds of the total revenue is contributed by the Roku platform which is a high-margin business.
Related Stock Price Articles
Currently, the count of active accounts on the Roku platform stands at 30.5 million users, while the content streamed is for a total of 9.4 billion hours. Considering these figures and the number of days in the quarter, i.e. 91 days, the average consumption can be totaled to 3.4 hours per day per account. The consumers are not only using low-cost devices but are also buying the now available smart TV with the factory-installed operating system of Roku.
While, Needham analyst, Laura Martin had been a keen supporter or Roku’s stock even before its bullish phase, even the cautious ones are now of the buying opinion – take for example Stephens’ and Rosenblatt’s analysts have changed the stock from neutral to buy last week.
To make matters even better, the media giants are also amidst the process of launching new streaming services. This, coupled with the rapid growth of Roku is what made the $150 stock price appear realistic when the stock had started the year at just $30. The future of the company definitely appears brighter than ever.
Stock Price Friday Morning Update – August 16, 2019
The Future Of Drug Delivery Has Biotech Investors Focusing On One Small Company
With a wave of groundbreaking products in the pipeline, biotechnology could be poised to keep churning higher for the foreseeable future. But how can you get in on the ground floor of the next big wave in biotech?
Will This New Trend In Tech Bolster Big Opportunities For Investors?
It is undeniable how on-demand is changing the world around us as we know it. No matter which business segment you belong to, chances are that someone in your industry will be thinking about investing in the on-demand market. So how can people capitalize on this new trend?
What’s Lying Ahead for Sohu.com (SOHU) After The Recent Developments
Sohu . com (SOHU) investors face a gloomy future after the stock of the Chinese company dropped to a new low in 16 years after it reported disappointing financial results last week. This is the first time since the spring of 2003 that the stock has sunk that low to trade in single digits.
What’s Lying Ahead for Sohu.com (SOHU) After The Recent Developments
Sohu.com (SOHU Stock Chart) investors face a gloomy future after the stock of the Chinese company dropped to a new low in 16 years after it reported disappointing financial results last week. This is the first time since the spring of 2003 that the stock has sunk that low to trade in single digits.
Sohu reports $474.8 million in revenue in Q2
In the just-announced Q2 2019 financial results the company reported revenue of around $474.8 million in the quarter which is a 2% decline from what was reported a year ago but it is a 10% sequential improvement. This is the fourth consecutive quarter that Sohu has posted a decline in year-over-year top-line although the pace has moderated with each passing quarter.
Things were not good equally for the subsidiaries that it spun sometimes as they also experienced a drop in their stock. Changyou.com (CYOU Stock Chart) and Sogou (SOGO Stock Chart) which represent Sohu’s gaming and search operations respectively equally tumbled last week hitting new lows despite the segments reporting an increase in revenue.
Q2 revenue within company projections
The company’s quarter did not appear to be disappointing since the reported revenue of $474.8 million was within the company’s projection of revenue between $469 and $494 despite falling short of Wall Street estimates. The adjusted net loss of $50 million reported was better than the projections of a loss of between $60 million and $70 million in the quarter.
Trending Stock Price Articles
The future for Sohu seems to be uncertain as it continues to perform unsatisfactorily. For instance, in the past year, the company saw its leading advertising revenue dip by 29% despite its Changyou-driven online gaming and Sogou-led search revenue increasing by 3% and 2% respectively.
For the third quarter, the company has estimated its revenue to be between $445 million and $470 million which is a sequential drop. The company has forecast a 10% to 14% jump in top-line which will help in offsetting the 12% to 21% drop in advertising revenue and 6% to 17% dip in online gaming revenue.
Search Stock Price (StockPrice.com)
Sponsored Content2 months ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured5 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Cannabis4 months ago
Two Massive Growth Industries, One Choice for Investors
Biotechnology2 months ago
Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks
Featured2 months ago
This New Technology Could Transform A Multi-Billion-Dollar Industry!
Cannabis3 months ago
A New Cannabis Trend That The Market Should Take Immediate Notice Of Is Here!
Biotechnology4 weeks ago
PharmaCyte Biotech (PMCB) and UTS Creating Advanced Version of Melligen Cells to Treat Diabetes
Biotechnology1 month ago
The Future Of Drug Delivery Has Biotech Investors Focusing On One Small Company